ClinicalTrials.gg
CompletedNCT03412214PI/AAIUpdated Mar 20, 2020

Validity of Perfusion Index to Evaluate the Level of General Anaesthesia in Children.

An observational study in Awareness, Anesthesia, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2020-03-20.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
41
Ages
4 Years to 12 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the validity of perfusion index to determine the level of anesthesia in comparison with auditory evoked potential in children undergoing tonsillectomy.

Read the detailed description

The use of the perfusion index as an added monitoring tool during anesthesia provides the anesthetist with a number of benefits. It is a useful tool to forewarn the clinician of possible light planes of anesthesia, allowing for agent dose adjustment. It is a preexisting technology that is already widely available and used in most urban, regional,and rural centers, in both developed and developing countries, is noninvasive, continuous, and inexpensive.

The AEP Monitor/2 (Danmeter A/S, Odense, Denmark), a commercialized system for depth of anesthesia monitoring, extracts the middle latency auditory evoked potentials (MLAEP) from the EEG-signal by using an autoregressive model with an exogenous input adaptive method

02

Conditions studied

  • Awareness, Anesthesia
03

In context

Intraoperative Awareness

55 studies on the registry are indexed under Intraoperative Awareness; 8 are open to participants now.

This study's enrollment of 41 is below the median of 120 across 28 observational studies indexed under Intraoperative Awareness.

Browse Intraoperative Awareness studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ASA physical status I-II patients aged 4-12 years and scheduled for elective tonsillectomy due to recurrent or chronic tonsillitis will be included in the study. Excluded from the study will be patients with significant cardiac, renal, pulmonary or hepatic disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 3-12 years
  • Elective tonsillectomy due to recurrent or chronic tonsillitis

Exclusion criteria

Exclusion Criteria:

  • Cerebral disease
  • Cardiac disease,
  • Renal disease,
  • Pulmonary disease
  • Hepatic disease.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
41 participants (actual)
Patient registry
No

Interventions

  • DevicePerfusion index detected by pulse oximeter

    Perfusion index detected by pulse oximeter

    Also known as: PI

  • DeviceAAI

    The AEP Monitor/2 (Danmeter A/S, Odense, Denmark), a commercialized system for depth of anesthesia monitoring, extracts the middle latency auditory evoked potentials (MLAEP) from the EEG-signal by using an autoregressive model with an exogenous input adaptive method.

    Also known as: AAI index detected by AEP monitor.

06

What researchers measure

Primary outcomes

  1. PI

    Perfusion index detected by pulse oximeter

    Time frame: Introperative

  2. AAI index

    AAI index detected by AEP monitor

    Time frame: Intraoperative

07

Study locations

1 site
  • Assiut university main hospital
    Assiut, Assiut Governorate 715715, Egypt
08

References and documents

Publications

  • Abdel-Ghaffar HS, Abdel-Wahab AH, Roushdy MM. Using the Perfusion Index to predict changes in the depth of anesthesia in children compared with the A-line Autoregression Index: an observational study. Braz J Anesthesiol. 2024 Sep-Oct;74(5):744169. doi: 10.1016/j.bjane.2021.04.030. Epub 2021 May 12. PubMed 33991553 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2018 to primary completion in Aug 2019, 17 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2018
First posted
Jan 26, 2018
StartActual
Mar 20, 2018
Primary completionActual
Aug 20, 2019
CompletionActual
Aug 20, 2019
Last update
Mar 20, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03412214
Lead sponsor
Assiut University
Responsible party
Hala Saad Abdel-Ghaffar (principal investigator, Assiut University) — Principal investigator
First posted
Jan 26, 2018
Start date
Mar 20, 2018
Primary completion
Aug 20, 2019
Completion
Aug 20, 2019
Last update
Mar 20, 2020

Study contacts

Hala S Abdelghaffar, MD
principal investigator · Professor in anesthesia and intensive care

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion